Waldenström's macroglobulinemia: a clinical perspective in the era of novel therapeutics

od Dimopoulos, M. A., Kastritis, E., Ghobrial, I. M.
Wydane w Ann Oncol (2016)

Candidate genes of Waldenström’s macroglobulinemia: current evidence and research

od Bianchi G, Sacco A, Kumar S, Rossi G, Ghobrial I, Roccaro A
Wydane 2013-07-01

Bone Marrow Microenvironment in Multiple Myeloma Progression

od Manier, S., Sacco, A., Leleu, X., Ghobrial, I. M., Roccaro, A. M.
Wydane 2012

Circulating tumor markers: harmonizing the yin and yang of CTCs and ctDNA for precision medicine

od Batth, I. S., Mitra, A., Manier, S., Ghobrial, I. M., Menter, D., Kopetz, S., Li, S.
Wydane w Ann Oncol (2017)

Distinct roles of class I PI3K isoforms in multiple myeloma cell survival and dissemination

od Sahin, I, Moschetta, M, Mishima, Y, Glavey, S V, Tsang, B, Azab, F, Manier, S, Zhang, Y, Maiso, P, Sacco, A, Azab, A K, Roccaro, A M, Ghobrial, I M
Wydane 2014

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma

od Witzig, T E, Reeder, C B, LaPlant, B R, Gupta, M, Johnston, P B, Micallef, I N, Porrata, L F, Ansell, S M, Colgan, J P, Jacobsen, E D, Ghobrial, I M, Habermann, T M
Wydane 2011

CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications

od Tai, Y-T, Landesman, Y, Acharya, C, Calle, Y, Zhong, MY, Cea, M, Tannenbaum, D, Cagnetta, A, Reagan, M, Munshi, AA, Senapedis, W, Saint-Martin, J-R, Kashyap, T, Shacham, S, Kauffman, M, Gu, Y, Wu, L, Ghobrial, I, Zhan, F, Kung, AL, Schey, SA, Richardson, P, Munshi, NC, Anderson, KC
Wydane 2013

Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma

od Manier, S., Park, J., Capelletti, M., Bustoros, M., Freeman, S. S., Ha, G., Rhoades, J., Liu, C. J., Huynh, D., Reed, S. C., Gydush, G., Salem, K. Z., Rotem, D., Freymond, C., Yosef, A., Perilla-Glen, A., Garderet, L., Van Allen, E. M., Kumar, S., Love, J. C., Getz, G., Adalsteinsson, V. A., Ghobrial, I. M.
Wydane w Nat Commun (2018)

Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials

od Potts, B.C., Albitar, M.X., Anderson, K.C., Baritaki, S., Berkers, C., Bonavida, B., Chandra, J., Chauhan, D., Cusack, J.C., Fenical, W., Ghobrial, I.M., Groll, M., Jensen, P.R., Lam, K.S., Lloyd, G.K., McBride, W., McConkey, D.J., Miller, C.P., Neuteboom, S.T.C., Oki, Y., Ovaa, H., Pajonk, F., Richardson, P.G., Roccaro, A.M., Sloss, C.M., Spear, M.A., Valashi, E., Younes, A., Palladino, M.A.
Wydane 2011